Literature DB >> 305739

Pi phenotypes and the prevalence of chest symptoms and lung function abnormalities in workers employed in dusty industris.

M Chan-Yeung, M J Ashley, P Corey, H Maledy.   

Abstract

Epidemiologic surveys were carried out on 1,138 white men employed in sawmills and grain elevator terminals in British Columbia. In addition to the administration of an occupational-health questionnaire and spirometry, Pi phenotype and the concentration of serum alpha1-antitrypsin were determined. Most of the workers (88.8 per cent) had the Pi M phenotype, whereas 8.0 per cent had the MS phenotype, and 2.7 per cent had the MZ phenotype. Very few workers (0.4 per cent) had other phenotypes. No differences were found among the 3 major phenotypes in the prevalence of chest symptoms and lung function abnormalities, even among cigarette smokers. These findings did not indicate that workers have the MZ phenotype with intermediate alpha-1-antitrypsin deficiency are particularly susceptible to the development of chronic obstructive lung disease under the conditions prevailing in these industries.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 305739     DOI: 10.1164/arrd.1978.117.2.239

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  8 in total

1.  Recommendations for reducing the effect of grain dust on the lungs. Canadian Thoracic Society Standards Committee.

Authors:  M Becklake; I Broder; M Chan-Yeung; J A Dosman; P Ernst; F A Herbert; S M Kennedy; P W Warren
Journal:  CMAJ       Date:  1996-11-15       Impact factor: 8.262

2.  Respiratory symptoms and pulmonary function in 871 miners according to Pi phenotype: a longitudinal study.

Authors:  F Pierre; Q T Pham; J M Mur; N Chau; J P Martin
Journal:  Eur J Epidemiol       Date:  1988-03       Impact factor: 8.082

3.  Assessment of alpha-1-antitrypsin deficiency heterozygosity as a risk factor in the etiology of emphysema. Physiological comparison of adult normal and heterozygous protease inhibitor phenotype subjects from a random population.

Authors:  D J McDonagh; S P Nathan; R J Knudson; M D Lebowitz
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

4.  Pulmonary emphysema associated with the FZ alpha 1-antitrypsin phenotype.

Authors:  D W Cockcroft; R K Tennent; S L Horne
Journal:  Can Med Assoc J       Date:  1981-03-15       Impact factor: 8.262

Review 5.  Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis.

Authors:  C P Hersh; M Dahl; N P Ly; C S Berkey; B G Nordestgaard; E K Silverman
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

6.  Alpha 1 antitrypsin and lung function in British coalminers.

Authors:  J E Boyd; P Collings; P M Crofton; G Blundell; J M Davis
Journal:  Br J Ind Med       Date:  1984-11

Review 7.  Estimated Prevalence and Number of PiMZ Genotypes of Alpha-1 Antitrypsin in Seventy-Four Countries Worldwide.

Authors:  Cristina Martinez-González; Ignacio Blanco; Isidro Diego; Patricia Bueno; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-09-17

8.  alpha 1-Antitrypsin deficiency and susceptibility to lung disease.

Authors:  H E Evans; N Bognacki
Journal:  Environ Health Perspect       Date:  1979-04       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.